The liver is one of the most resilient organs in the human body. It can regenerate. It can compensate. It can silently absorb damage for years — and keep working. And that is precisely what makes liver cancer so dangerous.
By the time most people in India are diagnosed with liver cancer, the tumour has already grown large. The liver has been compensating so effectively that no obvious symptoms were felt. And the window for curative treatment has narrowed dramatically.
Liver cancer is the sixth most common cancer in the world and the third leading cause of cancer-related deaths globally. In India, where chronic hepatitis B and C infections are prevalent and alcohol-related liver disease is rising rapidly, liver cancer is a growing and serious public health concern.
But here is what every patient and family needs to know: Bangalore is home to some of India’s finest hepatobiliary surgeons, liver transplant specialists and oncologists — equipped with world-class technology and offering treatment at a fraction of the cost of Western countries. When liver cancer is detected early and treated at the right centre, outcomes can be excellent.
This guide covers everything — from understanding what liver cancer is and how it develops, to symptoms, diagnosis, all treatment options, costs in Bangalore, and how to find the right specialist for your specific situation.
What Is Liver Cancer?
Liver cancer is the abnormal, uncontrolled growth of malignant cells in the liver — the large organ in the upper right side of the abdomen that filters blood, produces bile for digestion, metabolises nutrients and detoxifies harmful substances.
The liver is made up of several different types of cells — and cancer can develop in any of them. The type of cell in which the cancer originates determines the type of liver cancer, its behaviour and the most effective treatment approach.
It is critical to understand the difference between primary liver cancer (cancer that starts in the liver) and secondary (metastatic) liver cancer (cancer that starts elsewhere in the body and spreads to the liver).
Primary vs Secondary Liver Cancer
Primary Liver Cancer
Primary liver cancer originates in the liver cells themselves. The most common primary liver cancer is Hepatocellular Carcinoma (HCC) — accounting for 75-90% of all primary liver cancers. When people say “liver cancer,” they are usually referring to HCC.
Secondary (Metastatic) Liver Cancer
Secondary liver cancer starts in another organ — most commonly the colon, rectum, stomach, breast, lung or pancreas — and then spreads to the liver through the bloodstream or lymphatic system. Because the liver filters all blood from the digestive tract, it is one of the most common sites of cancer metastasis in the body.
Secondary liver cancer is far more common than primary liver cancer in most Western countries. In India, both primary and secondary liver cancers are significant concerns. Secondary liver cancer requires treatment of both the liver metastases and the primary cancer.
Types of Liver Cancer — A Complete Guide
1. Hepatocellular Carcinoma (HCC) — Most Common (75-90%)
HCC is by far the most common primary liver cancer, arising from hepatocytes — the main functional cells of the liver. The male-to-female ratio for HCC is approximately 4:1, and it typically presents between ages 40 and 70.
HCC is strongly associated with underlying liver disease — particularly cirrhosis (scarring of the liver) and chronic hepatitis B or C infection. In India, hepatitis B is the leading cause of HCC.
Subtypes of HCC:
- Fibrolamellar HCC — a rare subtype affecting younger patients (typically ages 20-40) without cirrhosis. It has a better prognosis than standard HCC and is more amenable to surgical resection
- Clear Cell HCC — a less common variant with variable prognosis
- Mixed Hepatocholangiocarcinoma — combines features of both HCC and bile duct cancer, more aggressive behaviour
2. Intrahepatic Cholangiocarcinoma (Bile Duct Cancer — 10-20%)
Cholangiocarcinoma develops in the bile duct cells — the tubes that carry bile from the liver to the small intestine. When it develops within the liver, it is called intrahepatic cholangiocarcinoma. It is the second most common primary liver cancer and accounts for 10-20% of cases.
Cholangiocarcinoma tends to be more aggressive and is often diagnosed at an advanced stage because it causes symptoms late. It is less associated with cirrhosis than HCC but is linked to primary sclerosing cholangitis, liver flukes and chronic bile duct inflammation.
3. Angiosarcoma and Haemangiosarcoma (Rare — less than 1%)
These rare cancers develop in the blood vessel cells lining the liver. They are extremely aggressive and typically diagnosed at a very advanced stage. They are associated with exposure to certain chemicals including vinyl chloride, arsenic and thorotrast (a contrast agent used historically in medical imaging).
4. Hepatoblastoma (Primarily in Children)
Hepatoblastoma is a rare cancer that occurs almost exclusively in young children — typically under 3-4 years of age. Children with hepatoblastoma experience abdominal swelling, pain and irritability. Despite being rare, it is the most common liver cancer in children. It generally responds well to treatment — particularly chemotherapy followed by surgery.
5. Secondary (Metastatic) Liver Cancer
Cancer spread to the liver from other primary sites — particularly colorectal cancer, gastric cancer, breast cancer, lung cancer and pancreatic cancer. Treatment depends on both the primary cancer type and the extent of liver involvement.
Warning Signs — Symptoms of Liver Cancer
Liver cancer is often called a “silent disease” — because in its early stages, it typically causes no symptoms at all. The liver has enormous reserve capacity and continues to function normally even with a significant tumour growing within it.
By the time symptoms develop, the cancer is often at an advanced stage. This is why people with known risk factors — chronic hepatitis, cirrhosis, heavy alcohol use — must undergo regular screening even without symptoms.
Primary Warning Signs
Pain or Discomfort in the Upper Right Abdomen The most common symptom — a dull ache or sharp pain in the upper right side of the abdomen, just below the rib cage. This pain may radiate to the right shoulder or back. It occurs as the growing tumour stretches the liver capsule or presses on surrounding structures.
Unexplained Weight Loss Significant and rapid weight loss without any change in diet or activity is a classic warning sign of liver cancer and many other cancers. The tumour diverts nutrients and the liver’s metabolic dysfunction contributes to loss of muscle mass and fat.
Loss of Appetite A marked decrease in appetite — not wanting to eat, feeling full after very small amounts of food — is extremely common in liver cancer. The enlarged liver pushes against the stomach, and metabolic changes affect hunger signals.
Abdominal Swelling (Ascites) Fluid buildup in the abdominal cavity — causing the abdomen to swell and feel tight, heavy and uncomfortable. This occurs when liver function deteriorates and the liver can no longer produce enough albumin to keep fluid in the blood vessels. Ascites can also result from tumour spread to the peritoneum.
Jaundice — Yellowing of Skin and Eyes A yellowing of the skin and whites of the eyes, often accompanied by dark urine (tea-coloured) and pale/clay-coloured stools. Jaundice occurs when the tumour blocks bile ducts or when liver function deteriorates to the point where bilirubin cannot be processed and excreted normally.
Nausea and Vomiting Persistent nausea — often worse after eating — is a common symptom of liver cancer related to liver dysfunction and the mechanical effect of the tumour on the stomach.
Extreme Fatigue A profound, persistent exhaustion that does not improve with rest. This results from the liver’s inability to properly process nutrients, metabolise toxins and maintain normal body chemistry.
A Hard Lump Under the Ribs on the Right Side In some cases, the enlarged liver or the tumour itself can be felt as a hard mass under the right rib cage. An enlarged spleen (splenomegaly) may also be palpable on the left side.
Additional Symptoms
- Itching skin (pruritus) — from bile salt accumulation under the skin when bile ducts are blocked
- Fever — low-grade fever not explained by infection
- Easy bruising or bleeding — from the liver’s reduced ability to produce clotting factors
- White or chalky stools — in cholangiocarcinoma when bile flow is blocked
- Leg swelling (oedema) — from reduced albumin production by the diseased liver
- Night sweats — particularly in cholangiocarcinoma
- Back pain — when the tumour presses on structures behind the liver
Causes and Risk Factors of Liver Cancer
1. Chronic Hepatitis B Infection — Leading Cause in India
Chronic infection with the Hepatitis B virus is the single biggest risk factor for liver cancer in India and Asia. India has a high prevalence of hepatitis B — and patients with chronic HBV who develop cirrhosis have a dramatically elevated risk of HCC. Hepatitis B vaccination — now part of India’s Universal Immunisation Programme — is one of the most effective preventive measures against liver cancer.
2. Chronic Hepatitis C Infection
Hepatitis C virus infection is the leading cause of HCC in Western countries and a significant contributor in India. Unlike hepatitis B, there is no vaccine for hepatitis C — but modern antiviral treatments can now cure hepatitis C in more than 95% of patients, significantly reducing HCC risk.
3. Liver Cirrhosis — The Common Pathway
Cirrhosis — irreversible scarring of the liver from any cause — is the most important risk factor for HCC. Approximately 70-80% of patients with HCC have underlying cirrhosis. Any condition that causes long-term liver damage and cirrhosis increases HCC risk — including chronic hepatitis B and C, alcohol-related liver disease, non-alcoholic steatohepatitis (NASH) and autoimmune hepatitis.
4. Heavy Alcohol Consumption
Chronic heavy alcohol use causes alcoholic liver disease which progresses from fatty liver to hepatitis to cirrhosis — and ultimately to HCC. Alcohol-related liver disease is a rapidly growing cause of liver cancer in urban India.
5. Non-Alcoholic Fatty Liver Disease (NAFLD) / NASH
NAFLD — caused by obesity, type 2 diabetes and metabolic syndrome — is rapidly becoming one of the leading causes of cirrhosis and liver cancer in India. As India’s obesity epidemic grows, so does the burden of NAFLD-related liver cancer.
6. Aflatoxin Exposure
Aflatoxins are toxins produced by the Aspergillus mould that grows on grains, peanuts and corn stored in warm, humid conditions — conditions common in many parts of India. Aflatoxin exposure is a significant risk factor for HCC, particularly in areas where food storage conditions are poor. Aflatoxin works synergistically with hepatitis B infection to dramatically increase HCC risk.
7. Type 2 Diabetes
Diabetes — particularly when combined with obesity or NAFLD — significantly increases the risk of liver cancer. Insulin resistance may promote liver cell proliferation.
8. Obesity
Obesity increases the risk of NAFLD, cirrhosis and subsequently liver cancer. As obesity rates rise in India, NAFLD-related liver cancer is expected to become increasingly prevalent.
9. Haemochromatosis
A genetic condition causing excessive iron absorption and accumulation in the liver, leading to cirrhosis and liver cancer over time.
10. Anabolic Steroids
Long-term use of anabolic steroids — increasingly common in India among bodybuilders and athletes — is associated with hepatocellular adenoma that can occasionally become cancerous.
11. Oral Contraceptive Pills
Long-term use of oral contraceptive pills has been associated with a slightly increased risk of hepatocellular adenoma and, rarely, liver cancer.
12. Exposure to Vinyl Chloride and Arsenic
Chemical exposure in certain industries is associated with angiosarcoma of the liver.
How Is Liver Cancer Diagnosed?
Early diagnosis is the key to curative treatment. For patients with known risk factors — particularly cirrhosis and chronic hepatitis B or C — regular surveillance ultrasounds every 6 months are recommended to detect tumours at an early, treatable stage.
Diagnostic Tests and Approximate Costs in Bangalore
| Test | Purpose | Approximate Cost |
|---|---|---|
| Ultrasound Abdomen | First-line screening for liver masses — inexpensive, widely available | ₹800 – ₹2,500 |
| CT Scan (Triphasic/4-phase) | Gold standard imaging for liver cancer — characteristic enhancement pattern distinguishes HCC from benign lesions | ₹5,000 – ₹12,000 |
| MRI Liver (with contrast) | More detailed than CT for small tumours and indeterminate lesions | ₹8,000 – ₹18,000 |
| PET-CT Scan | Full-body staging — detects spread to lymph nodes and distant organs | ₹15,000 – ₹28,000 |
| AFP Blood Test (Alpha-Fetoprotein) | Tumour marker — elevated in majority of HCC cases. Used for surveillance and monitoring | ₹500 – ₹1,500 |
| Liver Biopsy | Tissue confirmation — not always needed if imaging is characteristic, but used for atypical cases | ₹8,000 – ₹20,000 |
| Liver Function Tests (LFTs) | Assess overall liver function — critical for treatment planning | ₹1,000 – ₹3,000 |
| Hepatitis B and C serology | Identifies viral cause | ₹1,000 – ₹3,000 |
| Endoscopy | Check for varices (enlarged veins from portal hypertension) in patients with cirrhosis | ₹5,000 – ₹12,000 |
| Angiography | Mapping blood supply to the tumour before TACE or surgery | ₹15,000 – ₹30,000 |
| Fibroscan | Non-invasive assessment of liver stiffness and fibrosis | ₹3,000 – ₹6,000 |
| Genetic/Molecular Testing | For targeted therapy eligibility | ₹20,000 – ₹50,000 |
The BCLC Staging System for HCC
Liver cancer staging follows the Barcelona Clinic Liver Cancer (BCLC) system — which takes into account the tumour size and number, liver function (Child-Pugh score), portal vein invasion, distant spread and the patient’s performance status.
| BCLC Stage | Description | Preferred Treatment |
|---|---|---|
| Very Early (0) | Single tumour ≤2cm, preserved liver function | Surgery or ablation — best outcomes |
| Early (A) | Single tumour or up to 3 nodules ≤3cm, preserved liver function | Surgery, transplant or ablation — curative intent |
| Intermediate (B) | Multi-nodular, no vascular invasion, preserved liver function | TACE (chemoembolisation) |
| Advanced (C) | Vascular invasion or extra-hepatic spread | Targeted therapy / Immunotherapy |
| Terminal (D) | End-stage liver function | Palliative / Best supportive care |
Treatment Options for Liver Cancer in Bangalore
Liver cancer treatment is highly individualised — planned by a multidisciplinary team including a hepatobiliary surgeon, liver transplant surgeon, interventional radiologist, medical oncologist and radiation oncologist.
1. Surgery — Liver Resection (Hepatectomy)
Surgical removal of the tumour with a margin of healthy liver tissue is the most effective curative option for HCC in patients with good liver function and no cirrhosis. The liver’s remarkable ability to regenerate means that up to 70% of the liver can be removed — and the remaining liver will grow back to near-normal size within weeks.
Types of liver resection:
- Partial hepatectomy — removal of a segment or lobe of the liver containing the tumour
- Extended hepatectomy — removal of a larger portion of the liver
- Laparoscopic liver resection — minimally invasive surgery through small incisions, available at leading Bangalore centres. Results in less pain, shorter recovery and less blood loss
- Robotic liver resection — the most advanced approach, available at Apollo, Manipal and HCG in Bangalore
Who is eligible for surgery? Patients with a single tumour confined to the liver, preserved liver function (Child-Pugh A or B), no vascular invasion and no spread outside the liver. Patients with underlying cirrhosis need careful assessment — surgery may not be safe if cirrhosis is severe.
2. Liver Transplantation — The Best Cure for Early HCC with Cirrhosis
For patients who have HCC within the Milan Criteria (single tumour ≤5cm, or up to 3 tumours none larger than 3cm) AND underlying cirrhosis that makes surgical resection unsafe — liver transplantation offers the best chance of long-term cure.
Liver transplant simultaneously removes the cancer AND replaces the diseased, cirrhotic liver with a healthy one — eliminating both the tumour and the pre-cancerous background from which new tumours could develop.
Liver transplant survival rates in India: According to published data from top Indian transplant centres including a large NIH/PMC cohort study, the overall survival at 1 year is 84.3%, at 5 years is 75.5% and at 10 years is 72.2% — comparable to the best international centres.
Types of liver transplant:
- Living Donor Liver Transplant (LDLT) — a family member donates the right lobe of their liver. This is the most common type in India due to the shortage of deceased donors. The donor lives a completely normal life with the remaining liver
- Deceased Donor Liver Transplant (DDLT) — using a liver from a brain-dead donor. Availability is limited in India but improving
Cost of liver transplant in India: Living donor liver transplant costs ₹15 lakh to ₹30 lakh at leading Indian centres — a fraction of the USD 300,000 to USD 500,000 (₹2.5 crore – ₹4 crore) cost in the United States.
3. Radiofrequency Ablation (RFA)
RFA uses heat generated by radiofrequency energy to destroy tumour cells. A needle-like probe is inserted directly into the tumour — under CT or ultrasound guidance — and radiofrequency waves generate heat that destroys the cancer cells while preserving surrounding healthy liver tissue.
Best for: Small HCC tumours (typically ≤3-4cm) in patients who are not surgical candidates. RFA can be performed percutaneously (through the skin), laparoscopically or during open surgery.
Results for small HCC are excellent — comparable to surgery for tumours under 2cm in some studies.
4. Transarterial Chemoembolisation (TACE)
TACE is the standard treatment for intermediate-stage HCC — patients with multi-nodular disease confined to the liver but not suitable for surgery or transplant.
In TACE, an interventional radiologist threads a thin catheter through the femoral artery in the groin up to the hepatic artery (which supplies the liver tumour). Chemotherapy drugs are injected directly into the tumour’s blood supply — delivering a concentrated dose directly to the cancer — followed by injection of embolic material that blocks the blood supply, trapping the chemotherapy in the tumour and starving it of oxygen simultaneously.
TACE significantly extends survival in intermediate-stage HCC and can also be used as a “bridge” — to control tumour growth while a patient waits for liver transplant.
DEB-TACE (Drug-Eluting Bead TACE) — a more advanced version where the chemotherapy drug is loaded onto tiny beads that are injected into the tumour’s blood supply. This provides more sustained drug release with fewer systemic side effects.
5. Transarterial Radioembolisation (TARE / SIRT)
Similar in approach to TACE, but instead of chemotherapy, tiny beads loaded with a radioactive substance (Yttrium-90) are injected into the tumour’s blood supply. These radioactive beads lodge in the tumour and deliver intense radiation directly to the cancer cells from the inside.
TARE is particularly useful for large tumours, tumours near major blood vessels, and patients who cannot tolerate TACE. It is available at leading centres in Bangalore.
6. Microwave Ablation (MWA)
Similar in principle to RFA but uses microwave energy instead of radiofrequency energy. MWA can achieve higher temperatures faster and is effective for larger tumours that RFA may not completely destroy. It is increasingly available at top Bangalore centres.
7. Stereotactic Body Radiation Therapy (SBRT)
SBRT delivers highly precise, high-dose radiation to liver tumours in a small number of treatment sessions (typically 3-6). It is used for patients with HCC who cannot undergo surgery, ablation or TACE — particularly those with portal vein tumour thrombus. Multiple studies have shown that SBRT is a safe alternative to conventional bridging therapies in India.
Advanced SBRT systems available in Bangalore include CyberKnife, TrueBeam and TomoTherapy.
8. Targeted Therapy — Sorafenib, Lenvatinib and Beyond
For patients with advanced (BCLC Stage C) HCC — with vascular invasion or extra-hepatic spread — targeted therapy is the standard of care.
Sorafenib (Nexavar) was the first targeted therapy approved for advanced HCC and remained the standard first-line treatment for many years. It extends median survival by approximately 3 months compared to placebo.
Lenvatinib (Lenvima) has now been established as an alternative first-line treatment for advanced HCC — with comparable efficacy to sorafenib and in some studies superior results in certain patient subgroups.
Second-line options for patients who progress on sorafenib include: Regorafenib, Cabozantinib and Ramucirumab.
9. Immunotherapy — A New Era for Liver Cancer
Immunotherapy has transformed the treatment landscape for advanced liver cancer.
Atezolizumab + Bevacizumab (Tecentriq + Avastin) — this combination is now the preferred first-line treatment for patients with advanced HCC with good liver function. In the landmark IMbrave150 trial, this combination significantly outperformed sorafenib in overall survival and progression-free survival.
Nivolumab (Opdivo) and Pembrolizumab (Keytruda) are used in second-line settings for HCC.
Tremelimumab + Durvalumab (Imjudo + Imfinzi) — another immunotherapy combination now approved for unresectable HCC.
10. Chemotherapy
Traditional intravenous chemotherapy is generally not very effective for primary liver cancer (HCC) — the liver metabolises chemotherapy drugs rapidly, reducing their effectiveness and increasing toxicity. However, chemotherapy is used for certain types including cholangiocarcinoma (Gemcitabine + Cisplatin is the standard regimen) and hepatoblastoma in children (Cisplatin-based regimens).
11. Palliative Care
For patients with end-stage liver cancer where curative or life-extending treatment is not appropriate, expert palliative care focuses on managing symptoms — particularly pain, ascites, jaundice and fatigue — and maintaining quality of life and dignity.
Liver Cancer Treatment Cost in Bangalore — 2026
Surgery Costs
| Procedure | Estimated Cost in Bangalore |
|---|---|
| Liver resection (open surgery) | ₹3,50,000 – ₹6,00,000 |
| Laparoscopic liver resection | ₹5,00,000 – ₹8,00,000 |
| Robotic liver resection | ₹7,00,000 – ₹12,00,000 |
| Living Donor Liver Transplant (LDLT) | ₹15,00,000 – ₹30,00,000 |
| Deceased Donor Liver Transplant (DDLT) | ₹18,00,000 – ₹35,00,000 |
Interventional & Ablation Costs
| Procedure | Estimated Cost |
|---|---|
| Radiofrequency Ablation (RFA) | ₹1,50,000 – ₹3,00,000 |
| Microwave Ablation (MWA) | ₹1,50,000 – ₹3,50,000 |
| TACE (Transarterial Chemoembolisation) | ₹1,50,000 – ₹3,00,000 per session |
| DEB-TACE (Drug-Eluting Bead TACE) | ₹2,00,000 – ₹4,00,000 per session |
| TARE / SIRT (Y-90 Radioembolisation) | ₹6,00,000 – ₹12,00,000 |
Radiation & Systemic Treatment Costs
| Treatment | Estimated Cost |
|---|---|
| SBRT (full course) | ₹2,50,000 – ₹5,00,000 |
| Sorafenib / Lenvatinib (per month) | ₹40,000 – ₹80,000 |
| Immunotherapy (Atezolizumab + Bevacizumab per cycle) | ₹2,00,000 – ₹5,00,000 |
| Chemotherapy per cycle (cholangiocarcinoma) | ₹30,000 – ₹80,000 |
India vs World — Cost Comparison
| Country | Liver Cancer Treatment Cost |
|---|---|
| United States | USD 1,50,000 – USD 5,00,000 (₹1.25 crore – ₹4.2 crore) |
| United Kingdom | GBP 60,000 – GBP 2,00,000 (₹66 lakh – ₹2.2 crore) |
| Singapore | USD 50,000 – USD 1,50,000 (₹42 lakh – ₹1.25 crore) |
| Bangalore, India | ₹2,00,000 – ₹30,00,000 |
Bangalore offers savings of 70-90% compared to Western countries — with outcomes at top centres matching international benchmarks.
Survival Rates — What the Data Shows
| Stage / Treatment | 5-Year Survival Rate |
|---|---|
| Very Early HCC (surgical resection) | 60 – 80% |
| Early HCC (liver transplant within Milan criteria) | 70 – 80% |
| Early HCC (RFA for small tumours) | 40 – 70% |
| Intermediate HCC (TACE) | 20 – 40% |
| Advanced HCC (targeted therapy / immunotherapy) | 10 – 20% |
| Liver transplant (1-year survival — India) | 84 – 90% |
| Liver transplant (5-year survival — India) | 70 – 80% |
The most important message: survival rates drop dramatically with each stage. A patient with a single small HCC tumour treated with surgical resection can have a 5-year survival rate of 60-80%. A patient with advanced metastatic disease has a 5-year survival rate of less than 15%. Early detection is everything.
Best Hospitals for Liver Cancer Treatment in Bangalore
| Hospital | Key Strength |
|---|---|
| Apollo Hospitals, Bannerghatta Road | Liver transplant programme (4,500+ transplants across network), robotic surgery, advanced interventional radiology, TrueBeam SBRT |
| Manipal Hospital, Old Airport Road | Hepatobiliary surgery, liver transplant, TACE, advanced oncology |
| HCG Cancer Centre, Bangalore | India’s largest cancer network, advanced radiation oncology, targeted therapy, immunotherapy |
| Fortis Hospital, Bannerghatta Road | Liver surgery, TACE, interventional oncology |
| Narayana Health — Mazumdar Shaw | Liver transplant, affordable treatment, advanced oncology |
| BGS Gleneagles Global Hospital | Dedicated liver transplant and hepatobiliary surgery centre |
| Sri Shankara Cancer Hospital | Cancer-specific care, radiation oncology |
Prevention — How to Reduce Your Liver Cancer Risk
Unlike many cancers, significant prevention of liver cancer is possible:
1. Get Vaccinated Against Hepatitis B The hepatitis B vaccine is safe, effective and available across India — now part of the national immunisation programme. Adults who have not been vaccinated should discuss vaccination with their doctor.
2. Get Tested and Treated for Hepatitis B and C All adults — particularly those with risk factors — should be tested. Hepatitis B can be effectively managed with antiviral therapy that reduces liver damage and HCC risk. Hepatitis C can now be cured in over 95% of cases with 12 weeks of oral antiviral therapy.
3. Limit Alcohol Consumption Reducing or eliminating alcohol consumption is one of the most powerful steps for liver health. Even moderate drinking contributes to liver damage over time.
4. Maintain a Healthy Weight Obesity and type 2 diabetes drive NAFLD — a growing cause of liver cancer in India. A healthy diet and regular physical activity protect the liver.
5. Avoid Aflatoxin Exposure Store grains, nuts and legumes in dry, cool conditions to prevent mould growth. Avoid consuming visibly mouldy food.
6. Regular Surveillance for High-Risk Patients If you have cirrhosis, chronic hepatitis B or C, or other risk factors — regular ultrasound every 6 months with AFP blood test is recommended to detect early tumours when they are most treatable.
How Doctor Visit Bangalore Can Help
Liver cancer treatment — whether surgery, transplant, TACE or systemic therapy — requires not just skilled doctors but the right hospital with the right technology and a team experienced in managing this complex disease.
Doctor Visit Bangalore is here to help you navigate this journey with clarity:
✅ Find the most experienced hepatobiliary surgeon and liver cancer specialist in Bangalore for your specific situation
✅ Get a second opinion before committing to a treatment plan
✅ Arrange liver transplant evaluation and donor workup at the right centre
✅ Compare hospitals, treatment options and costs transparently
✅ Book confirmed appointments quickly — no long waiting
✅ Full support for international patients — visa assistance, airport pickup, accommodation
✅ Connect you with financial counsellors for insurance, Ayushman Bharat and medical loan options
✅ 24/7 WhatsApp support throughout your treatment journey
Frequently Asked Questions
Q: What is the most common type of liver cancer in India? Hepatocellular Carcinoma (HCC) is the most common primary liver cancer in India, accounting for 75-90% of cases. It is strongly associated with chronic hepatitis B infection and cirrhosis.
Q: Can liver cancer be cured? Yes — particularly when detected at an early stage. Single small tumours treated with surgery or liver transplantation have 5-year survival rates of 60-80%. Advanced-stage liver cancer is harder to cure but can often be managed for extended periods with modern targeted therapy and immunotherapy.
Q: What is TACE and is it available in Bangalore? TACE (Transarterial Chemoembolisation) is a minimally invasive procedure where chemotherapy is delivered directly to the liver tumour through its blood supply. It is available at all major hospitals in Bangalore including Apollo, Manipal, Fortis and HCG.
Q: Is liver transplant the best treatment for liver cancer? For patients with early-stage HCC within the Milan Criteria AND underlying cirrhosis, liver transplant offers the best chance of long-term cure — because it removes both the cancer and the cirrhotic liver from which new tumours could develop. For patients with good liver function and no cirrhosis, surgical resection may be equally or more effective.
Q: What is the cost of liver cancer treatment in Bangalore? Costs range from ₹1,50,000 for ablation procedures to ₹30,00,000 for liver transplantation. This is 70-90% less than equivalent treatment in the USA, UK or Singapore.
Q: Can fatty liver lead to liver cancer? Yes. Non-alcoholic fatty liver disease (NAFLD) — caused by obesity and diabetes — can progress to non-alcoholic steatohepatitis (NASH), then cirrhosis, and ultimately liver cancer. This is a rapidly growing cause of liver cancer in urban India.
Q: Does hepatitis B always lead to liver cancer? No — but chronic hepatitis B significantly increases the risk. Not everyone with hepatitis B develops liver cancer, but regular monitoring and antiviral treatment dramatically reduce this risk. This is why all people with chronic hepatitis B should be under regular medical care.
Q: What is the AFP blood test and what does it measure? Alpha-fetoprotein (AFP) is a protein produced by liver cells. In many patients with HCC, AFP levels are elevated in the blood. It is used as a surveillance marker for HCC in high-risk patients and to monitor treatment response. However, it is not specific to liver cancer and can be elevated in other conditions.
Final Thoughts — The Silent Threat You Can Fight
Liver cancer is silent — until it is not. By the time symptoms appear, the disease has often already advanced. But this does not have to be your story.
If you have hepatitis B or C, cirrhosis, diabetes, heavy alcohol use or any of the other risk factors described in this guide — regular surveillance is not optional. It is essential. A 6-monthly ultrasound and AFP test can detect liver cancer at a stage when it is still curable.
And if you or a loved one has already been diagnosed — know that Bangalore has world-class surgeons, transplant teams, interventional radiologists and oncologists who treat liver cancer every day, with outcomes that rival the best centres in the world, at a fraction of the cost.
Doctor Visit Bangalore is here to connect you with the right specialist, at the right hospital, at the right time.
📞 Call / WhatsApp: +91 78920 28951 🌐 www.doctorvisitbangalore.com
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a qualified hepatobiliary surgeon, liver transplant specialist or oncologist for diagnosis and treatment of liver cancer.